Complex formulation of 3-hydroxy-3-methyl glutaryl CoA reductase inhibitor and antihypertensive agent, and process for preparing same

Details for Australian Patent Application No. 2005320361 (hide)

Owner Hanmi Pharm. Co., Ltd.

Inventors Chi, Moon Hyuk; Kim, Yong Il; Woo, Jong Soo

Agent Cullen & Co

Pub. Number AU-B-2005320361

PCT Pub. Number WO2006/071077

Priority 10-2004-0116328 30.12.04 KR

Filing date 28 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 5 February 2009

International Classifications

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/071077 Priority application(s): WO2006/071077

5 February 2009 Application Accepted

  Published as AU-B-2005320361

4 June 2009 Standard Patent Sealed

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005320362-Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof

2005320359-Digital x-ray camera